Medication Therapy Management With Pharmacogenetic Testing

Status Completed

Clinical Trial Summary

This study aims to investigate the benefit and feasibility of providing pharmacogenetic (PGx) testing as part of a standard medication therapy management (MTM) session for patients taking multiple medications, a high-risk population for adverse drug reactions and non-response. Research participants will attend two MTM sessions and undergo PGx testing to inform the MTM plan. Participants will also complete 2 surveys pre and post-MTM/PGx testing. Data analysis will assess the impact of MTM/PGx testing on recommendations for drug dosing, clinical outcomes, patient satisfaction, and feasibility of service delivery. Safety issues are minimal with the primary risks being associated with loss of confidentiality, typical discomfort associated with acquiring blood samples, and genetic discrimination.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01970774
Study type	Interventional
Source	Duke University
Contact
Status	Completed
Phase	N/A
Start date	November 2013
Completion date	October 2014

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03258151` - Association of Genetic Polymorphisms With Docetaxel-based Chemotherapy Toxicities in Chinese Solid Tumor Patients
Withdrawn	`NCT04893395` - Assessment of the Impact of Clinical Pharmacogenomics on Real and Potential Medication Use in Veterans	N/A
Completed	`NCT03385473` - Individualized Antiretroviral Therapy	N/A
Completed	`NCT00757029` - Pharmacogenetic Study of Methylphenidate in Attention Deficit/Hyperactivity Disorder(ADHD)	Phase 4
Recruiting	`NCT05063838` - Perioperative Pharmacogenomic Testing	N/A
Completed	`NCT03276598` - A Study on Molecular Genetics of Drug Responsiveness in Essential Hypertension	Phase 4
Completed	`NCT03154489` - Effectiveness of a Multidisciplinary Medication Review With Follow-up for Patients Treated With Coumarin Anticoagulants in Primary Care	N/A
Not yet recruiting	`NCT03996356` - Clozapine Induced Weight Gain
Completed	`NCT00997789` - Bioequivalence of Rebamipide in Korean	N/A
Recruiting	`NCT01204086` - Pharmacogenomics Studies of Antidepressants	Phase 4
Not yet recruiting	`NCT05247814` - Individual Risk Profiles for Adverse Drug Reactions in Geriatric Patients
Completed	`NCT00833443` - Study of Medical Treatment for Methamphetamine Addiction	Phase 2
Recruiting	`NCT04449471` - Naproxen Pharmacogenetic Study (Project 1, Aim 2)	Phase 4
Recruiting	`NCT05805241` - Pharmacogenetics Analysis of Fentanyl Administered in Newborns
Completed	`NCT02937545` - Delivery of Pharmacogenetic Testing in a Community Pharmacy Setting	N/A
Enrolling by invitation	`NCT01259973` - Typical Versus Atypical Antipsychotics; Occupation of Striatal Receptors and the Appearance of Extrapyramidal Symptomatology, in Healthy Volunteers	Phase 1
Active, not recruiting	`NCT03258099` - Association of Genetic Polymorphisms With Capecitabine-based Chemotherapy Toxicities in Chinese Solid Tumor Patients
Recruiting	`NCT05307718` - Pharmacogenomics in Prediction of Cardiovascular Drugs Adverse Reaction
Recruiting	`NCT04964310` - Screening of Susceptibility Genes for APAP Induced Drug Induced LIver Injury in ChiNese Population: a Case-control Study
Completed	`NCT02383290` - The Implementation of Pharmacogenomics Into Primary Care in British Columbia	N/A